University of North Carolina (UNC) Chapel Hill researchers and local industry scientists secured $20 million in the from of a research contract targeting a cure for HIV. The deal was executed between ViiV Healthcare and UNC at Chapel Hill to renew the unique, public-private research partnership solely focused on discovering a cure for HIV. ViiV was set up by GSK and Pfizer, and later Shiongi joined the group.
HIV Still a Challenge
About 1.1 million live with HIV in America. Up to 14% of this population is unaware of their status and need testing. The disease impacts certain demographic groups disproportionately particularly racial and ethnic minorities and gay and bisexual male populations. An estimated 38,000 new HIV cases still occur each year in the United States. Although many of these could have been prevented and from a geographic clustering strategy certain regions are key for research and prevention strategies –more than 50% of the new HIV diagnoses occur in 48 counties, Washington DC, and San Juan Puerto Rico from 2016 to 2017 for example.
Worldwide, 37 million live with HIV. While highly active antiretroviral therapy (HAART) introduced the opportunity for a majo...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).